RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
RAS/MAPK 激活与三阴性乳腺癌中肿瘤浸润淋巴细胞减少有关：MEK 与 PD-1/PD-L1 免疫检查点抑制剂之间的治疗协同作用
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-15-1125
Sherene Loi, Sathana Dushyanthen, Paul A Beavis, Roberto Salgado, Carsten Denkert, Peter Savas, Susan Combs, David L Rimm, Jennifer M Giltnane, Monica V Estrada, Violeta Sánchez, Melinda E Sanders, Rebecca S Cook, Mark A Pilkinton, Simon A Mallal, Kai Wang, Vincent A Miller, Phil J Stephens, Roman Y
信号转导
肿瘤
乳腺癌
其它细胞
FCM
IF
IHC-P
WB
Checkpoint
MAPK/ERK
Human
